Author

Nanami Kosaka

Observed names: N Kosaka, N. Kosaka

Institution: The University of Tokyo

Observed institutions: Hyogo Prefectural Amagasaki General Medical Center, Pfizer (Japan), The University of Tokyo, Dokkyo Medical University

ORCID: 0009-0004-7081-9641

Observed ORCID: 0009-0004-7081-9641

OpenAlex ID: A5109759200

Imaging of brain tumor, lung cancer, esophagus cancer, colon cancer, prostate cancer, and bladder cancer with [C-11]choline

1997 · Oichiro Kobori, Hirofumi Kishi, et al. · Journal of Nuclear Medicine · 27

Complications of laser conization versus loop electrosurgical excision procedure in pre- and postmenopausal patients.

2016 · K Kiuchi, K Hasegawa, et al. · PubMed · 8

Chloroplast‐ and mitochondrion‐specific random C‐to‐T mutagenesis for forward genetics of organelle genomes

2026 · Nanami Kosaka, Yoshiki Harada, et al. · The Plant Journal · 4

Letter Regarding “Radiotherapy Improves Survival in NSCLC After Oligoprogression on Immunotherapy: A Cohort Study”

2024 · Nanami Kosaka, Yuki Kataoka · JTO Clinical and Research Reports · 2

359P Overall survival of palbociclib (PAL) + endocrine therapy (ET) in Japanese patients with hormone receptor-positive (HR+)/ human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC) in the 1st line (1L) or 2nd line (2L) setting: A multicenter observational study

2024 · T. Nakayama, S.E. Nagai, et al. · Annals of Oncology · 1

Highlights from the 14th International Conference for Plant Mitochondrial Biology: current trends and future directions

2026 · Jingxiu Ji, Rika Nakajima, et al. · Plant and Cell Physiology

Letter regarding “The significance of inflammatory markers in prognosticating the effectiveness and safety of immunotherapy in conjunction with chemotherapy during the primary intervention of advanced non-small cell lung carcinoma”

2024 · Nanami Kosaka, Yuki Kataoka · Lung Cancer

Letter Regarding “Clinical Utility of Circulating Tumor DNA in Patients With Advanced KRASG12C-Mutated NSCLC Treated With Sotorasib”

2024 · Nanami Kosaka, Yuki Kataoka · Journal of Thoracic Oncology

154 Clinical indicators useful in decision-making about palliative chemotherapy for end-of-life ovarian cancer patients

2020 · K. Hasegawa, K. Kiuchi, et al. · International Journal of Gynecological Cancer

Novel mechanism of bone metastasis mediated by exosomes derived from metastatic prostate cancer

2019 · F. Urabe, N. Kosaka, et al. · European Urology Supplements

Two cases of recurrent small-cell carcinoma of the uterine cervix treated with amrubicin as salvage chemotherapy

2019 · N. Kosaka, K. Hasegawa, et al. · European Journal of Gynaecological Oncology

[Update on microRNAs research in sarcoma: review the literature and proposal of the clinical application].

2013 · Tomohiro Fujiwara, Akira Kawai, et al. · PubMed

M348 Evaluation of Cyclic Chemotherapy for Stage Iii Ovarian Cancer

2012 · N. Kosaka, T. Okazaki, et al. · International Journal of Gynecology & Obstetrics

Works count: 13

Citation count: 42

H-index: 3

I10-index: 1